Our COVID Vaccine Statement and other related resources for patients and our researchers and research staff are available on the COVID-19 Updates webpage.
Terminated: April 10, 2020
To determine the prospective incidence of OC, fallopian tube cancer, breast cancer, PPC, and all cancer among women at increased risk of OC, with a special emphasis on women who are known BRCA1/2 mutation carriers.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.